Skip to main content

ATC 2024 Abstracts & Presentations

The American Transplant Congress (ATC) is the Joint Annual Meeting of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST).  ATC provides a forum for exchange of new scientific and clinical information relevant to solid organ and tissue transplantation. The event brings together transplant physicians, scientists, nurses, organ procurement personnel, pharmacists, allied health professionals and other transplant professionals. 

ATC 2024 will be taking place from June 1 - 5, 2024 in Philadelphia, PA. Below are this year's contributions from our team. 

Invited Presentations

Andres Duarte-Rojo, MD, MS, PhD

  • In-Depth Presentation: Lifestyle modification for management of MASLD: a help or a hindrance?
    • Saturday June 1, 1:30PM - 1:50PM EST 

Josh Levitsky, MD, MS

  • Presidential Address 
    • Sunday June 2, 9:45AM - 10:15AM EST 
  • Special Session: AST Update 
    • Tuesday June 4, 11:45AM - 12:00PM EST 

Anat Tambur, PhD, DMD

  • Hot Topic Debate Presentation: Expanding virtual crossmatch for DDKT - caution is advised! 
    • Monday June 3, 2:10PM - 2:30PM EST 

Moderators

Akansha Agrawal, MD

  • Rapid Fire Oral Abstract SessionKidney Desensitization and Immune Graft Failure
    • Tuesday June 4, 9:45AM - 10:45AM EST
  • Rapid Fire Oral Abstract Session - Kidney Immunosuppression: Desensitization
    • Wednesday June 5, 9:30AM - 10:30AM EST

Mohammed Javeed Ansari, MD

  • Rapid Fire Oral Abstract Session - Kidney Immunosuppression: Induction Therapy
    • Tuesday June 4, 9:45AM - 10:45AM EST 

Daniel Borja-Cacho, MD

  • Rapid Fire Oral Abstract Session - Machine Perfusion and Organ Rehabilitation - Basic
    • Tuesday June 4, 3:00PM - 4:00PM EST 

Hazel Domingo, MMSc, PA-C

  • Interactive Symposium - Maximizing Efficiency and Collaboration: The Integral Role of Advanced Practice Providers in Organ Procurement and Transplant Surgery
    • Sunday June 2, 1:30PM - 2:30PM EST 

John Friedewald, MD, FAST 

  • Plenary Oral Abstract Session 4
    • Wednesday June 5, 8:15AM - 9:15AM EST

Josh Levitsky, MD, MS

  • Plenary Oral Abstract Session 1
    • Sunday June 2, 8:15AM - 9:15AM EST

Satish Nadig, MD, PhD

  • Interactive Symposium - Cells on a Diet! The Impact of Diet on the Alloimmune Response
    • Sunday June 2, 7:00AM - 8:00AM EST 

Sook Park, MD, MSCI

  • Rapid Fire Oral Abstract Session - Kidney Living Donor: Other
    • Sunday June 2, 4:30PM - 5:30PM EST 

Vinayak Rohan, MD, FACS

  • Rapid Fire Oral Abstract Session - Kidney Deceased Donor Allocation - 2
    • Wednesday June 5, 9:30AM - 10:30AM EST 

Jes Sanders, MD 

  • Rapid Fire Oral Abstract Session - Treg Other Regulatory Cell Tolerance - 1
    • Saturday June 1, 4:30PM - 5:30PM EST

Zheng Zhang, MD, MSc 

  • Rapid Fire Oral Abstract Session - Chronic Organ Rejection
    • Monday June 3, 4:30PM - 5:30PM EST 

Plenary Oral Abstracts

Fifteen Year Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients

  • J. R. Leventhal{1}, J. Mehta{2}, J. Mathew{3}, L. Gallon{4}, A. Agrawal{3}, A. Tambur{3}, K. Ravindra{5}, M. Horwitz{6}, S. Ildstad{7}, {1}Surgery, Northwestern Medicine, Chicago, IL, {2}Stem Cell Transplantation and Cell Therapy, Northwestern Medicine, Chicago, IL, {3}Northwestern University, Chicago, IL, {4}Northwestern University NMFF, Chicago, IL, {5}Duke University Medical Center, Durham, NC, {6}Duke University, Durham, NC, {7}University of Louisville, Louisville, KY

Rapid Fire Oral Abstracts

Combining Blood Gene Expression, Plasma Cellfree DNA, and Urine Chemokines to Diagnose Rejection in Kidney Transplant Recipients

  • J. Friedewald{1}, L. Zhao{1}, S. Park{1}, M. Abecassis{2}, V. LaCombe{3}, G. Hanna{3}, B. Robelly{1}, C. Rebello{1}, T. Whisenant{4}, S. Kurian{5}, S. Kleiboeker{3};
    {1}Northwestern University, Chicago, IL, {2}University of Arizona, Tucson, AZ, {3}Eurofins - Viracor, Lenexa, KS, {4}UCSD, San Diego, CA, {5}Scripps, San Diego, CA

Social Deprivation Decreases Time to First Decompensation for Patients with Cirrhosis

  • J. E. Obayemi{1}, M. Paukner{1}, B. J. Hasjim{1}, A. Jain{2}, F. Crippa{2}, K. N. Kershaw{1}, T. Banea{3}, P. Advani{4}, E. Koep{4}, Y. Akintola{4}, L. B. VanWagner{5}, L. Zhao{1}, C. F. Manski{2}, D. P. Ladner{1}, {1}Northwestern University Feinberg School of Medicine, Chicago, IL, {2}Northwestern University, Evanston, IL, {3}Northwestern University, Chicago, IL, {4}UnitedHealth Group, Minneapolis, MN, {5}UT Southwestern Medical Center, Dallas, TX

Virtual Liver Transplant Games (VLTG): Leveraging Technology and Gamification to Promote Physical Activity in End-Stage Liver Disease Patients

  • A. Duarte-Rojo{1}, J. G. Stine{2}, B. M. Al-Judaibi{3}, M. S. Kriss{4}, P. M. Bloomer{5}, A. Tevar{5}, A. Desai{6}, M. R. Kappus{7}, J. Lai{8}, M. R. Porwit{1}, K. C. Specth{9}, M. E. Michta{9}, A. J. Thuluvath{1}, A. Daud{1}, D. P. Ladner{1}, E. D. Bethea{9}, {1}Northwestern, Chicago, IL, {2}Penn State U., Hershey, PA, {3}U. of Rochester, Rochester, NY, {4}U. of Colorado, Aurora, CO, {5}UPMC, Pittsburgh, PA, {6}Indiana U. School of Medicine, Indianapolis, IN, {7}Duke U. Health System, Raleigh, NC, {8}UCSF, San Francisco, CA, {9}Mass General Hospital, Cambridge, MA

A Home-Based Liver Frailty Intervention (LIFT) in Transplant Candidates: A Feasibility Study

  • A. J. Thuluvath{1}, P. Polineni{2}, S. Morrissey{3}, K. Belfanti{3}, M. Nizamuddin{2}, O. Siddiqui{2}, A. Daud{2}, D. Simpson{2}, J. Levitsky{1}, A. Flores{3}, A. Duarte-Rojo{1}, D. P. Ladner{2}, {1}Division of Hepatology, Northwestern University Feinberg School of Medicine, Chicago, IL, {2}Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, {3}Department of Physical Therapy and Human Movement Science, Northwestern University Feinberg School of Medicine, Chicago, IL

The TAKE IT Trial: An EHR-Based Surveillance Strategy to Promote Medication Adherence among Kidney Transplant Recipients

  • P. Zheng{1}, L. Curtis{1}, S. Hur{1}, M. Kwasny{1}, M. Serper{2}, S. Nair{3}, D. Ladner{4}, M. Wolf{1}, {1}Northwestern University, Chicago, IL, {2}University of Pennsylvania, Philadelphia, PA, {3}Mayo Clinic, Phoenix, AZ, {4}Northwestern Memorial Hospital, Chicago, IL

A Kidney Allograft Rejection Prediction Model Using Serial Gene Expression Profile and Donor-Derived Cell-Free DNA

  • L. Zhao, C. Rebello, J. Friedewald, K. Guo, S. Park, Northwestern University, Chicago, IL

Poor Calibration of Allocation Priority Weights for Sensitized Patients Significantly Impacts Equitable Access to Kidney Transplantation in the United States

  • J. Schold{1}, A.R. Tambur{2}, S. Mohan{3}, B. Kaplan{4}, {1}Surgery and Epidemiology, University of Colorado Anschutz Medical Campus, Aurora, CO, {2}Northwestern University, Chicago, IL, {3}Medicine, Columbia University, New York, NY, {4}Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO

Risk HLA-DQ Heterodimer Mismatch is Associated with De Novo Donor Specific Antibodies in Pediatric Kidney Transplant Recipients

  • V. Sigurjonsdottir{1}, K. Piburn{2}, L. Wang{3}, P. Grimm{3}, A. R. Tambur{4}, B. M. Zhang{3}, {1}University of Miami, Miami, FL, {2}University of Texas Health, San Antonio, TX, {3}Stanford University, Stanford, CA, {4}Northwestern University, Chicago, IL

Are All Eplets Created Equal - Is It Quantity of Quality That Matters?

  • E. Lazar-Molnar{1}, A. R. Tambur{2}, D. Jain{1}, Z. Zafar{3}, D. Morris{3}, S. Anand{3}, {1}University of Utah School of Medicine, Salt Lake City, UT, {2}Northwestern University, Chicago, IL, {3}Intermountain Medical Center, Salt Lake City, UT

HLA Eplet Matching as a Prognostic Biomarker of Kidney Transplant Outcomes

  • M. Raynaud{1}, Z. Demir{1}, K. Louis{2}, A. Truchot{1}, A. Zeevi{3}, R. Ponsirenas{4}, A. R. Tambur{5}, C. Lefaucheur{2}, A. Loupy{1}, {1}Paris Transplant Group, Paris, France, {2}Saint-Louis Hospital, Paris, France, {3}University of Pittsburgh Medical Center, Pittsburgh, PA, {4}Hospital Universitário Cajuru, Curitiba, Brazil, {5}Northwestern University, Chicago, IL

Kidney Function Recovery after Liver Transplantation: The Contrasting Roles of Inflammation and Tubular Repair

  • N. Goerlich{1}, S. Kim-Schulze{2}, P. Kotanko{3}, N. Grobe{3}, X. Wang{3}, P. Enghard{4}, M. Fribourg{2}, P. Cravedi{1}, J. Levitsky{5}, {1}Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY, {2}Icahn School of Medicine at Mount Sinai, New York, NY, {3}Renal Research Institute, New York, NY, {4}Charité Universitaetsmedizin Berlin, Berlin, Germany, {5}Northwestern University Feinberg School of Medicine, Chicago, IL

Torque Teno Virus Kinetics as a Measure of Net Immunosuppression in Kidney Transplant Recipients

  • L. Speroni{1}, N. Ahmed{2}, R. Sinha{3}, K. Guo{2}, L. Zhao{2}, C. Rebello{2}, S. Kleiboeker{3}, A. Desai{2}, B. Kinsella{2}, J. Friedewald{2}, {1}Chapman University, Orange, CA, {2}Northwestern University, Chicago, IL, {3}Eurofins - Viracor, Lenexa, KS

Living Donor Candidates’ Use of a Chatbot on APOL1 to Scale up Genetic Testing in Clinical Evaluation

  • E. J. Gordon{1}, J. Gacki-Smith{2}, D. Manning{2}, R. Yacat{3}, D. Jahangir{2}, D. Boachie{2}, T. Hall{3}, T. Truong{3}, C. Wicklund{4}, D. Duquette{2}, J. Friedewald{5}, A. Gilbert{3}, A. Agrawal{5}, {1}Surgery, Vanderbilt University Medical Center, Oak Park, IL, {2}Northwestern University Feinberg School of Medicine, Chicago, IL, {3}Georgetown University, Washington, DC, {4}Myriad, Chicago, IL, {5}Northwestern University, Chicago, IL

Beneficial Impact of CCR5 Blockade in Kidney Transplant Recipients with HIV

  • A. Brown{1}, B. Barin{2}, G. Roll{3}, S. Mehta{4}, S. Florman{5}, C. Durand{6}, T. Pearson{7}, M. Cooper{8}, V. Stosor{9}, E. Blumberg{10}, J. Husson{11}, S. Bunnapradist{12}, T. J. Henrich{1}, Z. Laszik{1}, M. Sarwal{1}, B. Alston-Smith{13}, J. Odim{14}, R. Rogers{1}, P. Stock{1}, {1}UCSF, San Francisco, CA, {2}Emmes, Rockville, MD, {3}Transplant Surgery, UCSF, San Francisco, CA, {4}UAB, Birmingham, AL, {5}Transplant Surgery, Mt Sinai, New York, NY, {6}JHU, Baltimore, MD, {7}Emory, Atlanta, GA, {8}Georgetown, Washington, DC, {9}Northwestern, Chicago, IL, {10}UPenn, Philadelphia, PA, {11}UMD, Baltimore, MD, {12}UCLA, Los Angeles, CA, {13}NIH NIAID, Rockville, MD, {14}NIH DAIT, Rockville, MD

Increased Rate of Deceased Donor Liver Transplant Rate for Candidates Willing to Receive Organs from Donors with HIV

  • Z. Nauroz{1}, M. Bowring{1}, S. Florman{2}, M. Rana{2}, J. Motter{3}, J. Price{4}, S. Mehta{3}, J. Hand{5}, D. Wojciechowski{6}, S. Aslam{7}, M. Malinis{8}, N. Elias{9}, G. Haidar{10}, M. Pereira{11}, J. Simkins{12}, V. Stosor{13}, C. Small{14}, J. Baddley{15}, M. Morsheimer{16}, D. Segev{3}, A. Massie{3}, C. Durand{1}, {1}JHU, Baltimore, MD, {2}Sinai, NYC, NY, {3}NYU, NYC, NY, {4}UCSF, San Francisco, CA, {5}Ochsner, New Orleans, LA, {6}UTSW, Dallas, TX, {7}UCSD, San Diego, CA, {8}Yale, New Haven, CT, {9}MGH, Milton, MA, {10}UPMC, Pittsburgh, PA, {11}Columbia, NYC, NY, {12}Univ of Miami, Miami, FL, {13}Northwestern, Chicago, IL, {14}Cornell, NYC, NY, {15}UMD, Baltimore, MD, {16}NIH, Rockville, MD

Kaposi Sarcoma-Associated Herpesvirus Seroprevalence and Disease in Kidney Transplant Recipients with HIV under the HOPE Act

  • T. Liang{1}, P. Nambiar{2}, M. Rana{3}, S. Florman{3}, M. Bowring{1}, W. Werbel{1}, N. Labo{4}, D. Whitby{4}, R. Friedman-Moraco{5}, P. Stock{6}, A. Gilbert{7}, S. Mehta{8}, V. Stosor{9}, S. Mehta{10}, M. Pereira{11}, C. Butkus Small{12}, M. Morris{13}, J. Hand{14}, S. Aslam{15}, J. Baddley{16}, G. Haidar{17}, M. Malinis{18}, C. Santos{19}, J. Schaenman{20}, R. La Hoz{21}, E. Blumberg{22}, N. Elias{23}, E. Giorgakis{24}, D. Segev{10}, C. Durand{1}, {1}JHU, Baltimore, MD, {2}Medicine, MSKCC, New York, NY, {3}Mt Sinai, NYC, NY, {4}NCI, Frederick, MD, {5}Emory, Atlanta, GA, {6}UCSF, San Francisco, CA, {7}Georgetown, Washington, DC, {8}UABMC, Birmingham, AL, {9}NW Univ, Chicago, IL, {10}NYU, NYC, NY, {11}Columbia, NYC, NY, {12}Cornell, NYC, NY, {13}Univ of Miami, Miami, FL, {14}Ochsner, New Orleans, LA, {15}UCSD, San Diego, CA, {16}UMD, Baltimore, MD, {17}UPMC, Pittsburgh, PA, {18}Yale, New Haven, CT, {19}Rush, Chicago, IL, {20}UCLA, Los Angeles, CA, {21}UTSW, Dallas, TX, {22}UPenn, Philadelphia, PA, {23}MGH, Boston, MA, {24}UAMS, Little Rock, AR

Risk of Viral Infections in Solid Organ Transplant Recipients Receiving Belatacept: A Systematic Review and Meta-Analysis

  • I. Tawhari{1}, F. Yamani{2}, {1}Internal Medicine, Nephrology, King Khalid University, Abha, Saudi Arabia, {2}Northwestern Memorial Hospital, Chicago, IL

Developing Clinical Case Studies to Prepare Transplant Teams for First-in-Human Pig Xenotransplant Clinical Trials

  • M. K. Gusmano{1}, K. Maschke{2}, J. Gacki-Smith{3}, M. Matthews{2}, B. Lopez-Patino{4}, K. Traboulsi{1}, D. Manning{3}, E. J. Gordon{5}, {1}Lehigh University, Bethlehem, PA, {2}The Hastings Center, Garrison, NY, {3}Northwestern University, Chicago, IL, {4}The Hastings Center, Bethlehem, NY, {5}Surgery, Vanderbilt University Medical Center, Oak Park, IL

Poster Abstracts

You are what you eat: Harnessing the power of endothelial cell autophagy as a potential donor organ pre-treatment strategy in cardiac transplantation 

  • M. E. Taylor, D. Jaishankar, L. Andrade da Silva, A. P. Strouse, Y. Lee, S. Nadig, Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL

Long-Term Mortality and Frailty Among Patients With Low MELD Cirrhosis, 2011-2021

  • B. J. Hasjim{1}, M. Paukner{1}, M. Mohammadi{2}, J. E. Obayemi{1}, D. J. Vitello{1}, T. Banea{1}, L. B. VanWagner{3}, A. Duarte-Rojo{1}, L. Zhao{1}, S. Mehrotra{2}, D. P. Ladner{1}, {1}Northwestern University Feinberg School of Medicine, Chicago, IL, {2}Northwestern University, Evanston, IL, {3}UT Southwestern Medical Center, Dallas, TX

Cost Burden of Cirrhosis and Liver Transplantation in Privately Insured Patients in the US: 2011-2020

  • B. J. Hasjim{1}, F. Obradović{2}, D. J. Vitello{1}, J. E. Obayemi{1}, A. Jain{2}, M. Gmeiner{3}, F. Crippa{2}, A. Duarte-Rojo{4}, L. Kulik{4}, T. Banea{1}, L. Zhao{5}, L. B. VanWagner{6}, C. F. Manski{2}, D. P. Ladner{1}, {1}Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, {2}Department of Economics, Northwestern University, Evanston, IL, {3}London School of Economics, London, United Kingdom, {4}Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, {5}Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, {6}Department of Medicine, UT Southwestern Medical Center, Dallas, TX

Rates Of Secondary Prevention Of Variceal Bleeding Differ By Race And Ethnicity

  • J. E. Obayemi{1}, M. Paukner{2}, B. J. Hasjim{1}, M. Mohammadi{3}, D. J. Vitello{1}, T. Banea{1}, L. B. VanWagner{4}, A. Duarte-Rojo{5}, L. Zhao{2}, S. Mehrotra{6}, D. P. Ladner{1}, {1}Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, {2}Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, {3}Industrial Engineering and Management Sciences, Northwestern University, Chicago, IL, {4}Medicine, University of Texas Southwestern Medical Center, Dallas, TX, {5}Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, {6}Industrial Engineering and Management Sciences, Northwestern University, Evanston, IL

Prevention Of Recurrent Variceal Bleeding Is Low Among Patients With ALD Cirrhosis

  • J. E. Obayemi{1}, M. Paukner{2}, B. J. Hasjim{1}, M. Mohammadi{3}, D. J. Vitello{1}, T. Banea{4}, L. B. VanWagner{5}, A. Duarte-Rojo{6}, L. Zhao{2}, S. Mehrotra{7}, D. P. Ladner{1}, {1}Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, {2}Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, {3}Industrial Engineering and Management Sciences, Northwestern University Feinberg School of Medicine, Evanston, IL, {4}Northwestern University, Chicago, IL, {5}Medicine, University of Texas Southwestern Medical Center, Dallas, TX, {6}Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, {7}Industrial Engineering and Management Sciences, Northwestern University, Evanston, IL

Pre-Transplant and Early Post-Transplant CD8+ Donor Reactive Clones May Predispose to Rejection in Kidney Transplant Recipients Receiving Non-Lymphodepletional Induction

  • J. M. Sanders{1}, B. L. Banbury{2}, E. L. Schumacher{2}, J. He{1}, J. R. Leventhal{1}, J. M. Mathew{1}, {1}Department of Surgery, Northwestern University, Chicago, IL, {2}Adaptive Biotechnologies, Seattle, WA

A Phase 2 Study of Regulatory T Cell Therapy to Achieve Immunosuppression (IS) Reduction in Living Donor Kidney Transplant (LDKTx) Recipients: The RETIRE Trial

  • J. R. Leventhal{1}, C. Stratton{2}, J. Mathew{3}, C. Yang{4}, S. Murray{2}, {1}SURGERY, Northwestern Medicine, Chicago, IL, {2}TRACT Therapeutics, Chicago, IL, {3}Northwestern University, Chicago, IL, {4}Taiwan Bio, Taipei, Taiwan

Single Center Experience with the FREEDOM 1 Trial (NCT03995901), a Randomized Controlled Study to Evaluate the Safety, Efficacy, and Overall Benefit of FCR001 Cell Therapy in De Novo Living Donor Renal Transplantation

  • J. R. Leventhal{1}, J. Mehta{2}, L. Gallon{1}, A. Agrawal{1}, J. Mathew{1}, S. Ildstad{3}, {1}Northwestern, Chicago, IL, {2}Stem Cell Transplantation and Cell Therapy, Northwestern Medicine, Chicago, IL, {3}University of Louisville, Louisville, KY

Real World Experience of Combining Blood Gene Expression and Donor-Derived Cell-Free DNA for Diagnosing Kidney Allograft Rejection

  • S. Park{1}, K. Guo{1}, L. Zhao{2}, S. Kleiboeker{3}, J. Friedewald{1}, {1}Northwestern University, Chicago, IL, {2}Northwestern University, chicago, IL, {3}Viracor Eurofins, Lees Summit, MO

Unfolded Protein Response in Myeloid Cells Controls Tubular Epithelial Regeneration of Renal Allograft via TWEAK-Fn14 Signaling Pathway

  • J. Cai, X. Zheng, W. Yuen, J. Wang, L. VanOsdol, Z. J. Zhang, Comprehensive Transplant Center and Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL

Utilization of A2 and A2B to B Kidney Transplantation among Transplant Centers with Large Black Patient Populations

  • K. Atiemo{1}, E. Oguntuwase{2}, D. Ladner{3}, {1}Weill Cornell Surgery, NY, NY, {2}Weill Cornell, NY, NY, {3}Northwestern Memorial Hospital, Chicago, IL

Association of Immunosuppression Status as Defined by Torque Teno Virus Load and Clinical Outcomes in Kidney Transplant Recipients

  • N. Ahmed{1}, L. Speroni{2}, K. Guo{2}, A. Desai{2}, C. Rebello{2}, S. Kleiboeker{2}, B. Kinsella{2}, J. Friedewald{2}, A. Desai{2}, {1}Arizona College of Osteopathic Medicine, Glendale, AZ, {2}Northwestern University, Chicago, IL

Changes in Peripheral Blood Gene Expression and Cell Type Abundance during Treatment for Acute Rejection in Kidney Transplant Recipients

  • T. Whisenant{1}, C. Rebello{2}, K. Guo{2}, S. Park{2}, L. Zhao{2}, M. Abecassis{3}, J. Friedewald{2}, {1}UCSD, San Diego, CA, {2}Northwestern University, Chicago, IL, {3}University of Arizona, Tucson, AZ

Sociodemographic Correlates of Barriers to Progression from Living Donor Candidate Evaluation to Donor Approval: Analysis of the SRTR Living Donor Collective

  • K. L. Lentine{1}, A. Hart{2}, Y. Ahn{3}, D. Brennan{4}, P. Dean{5}, M. Doshi{6}, A. Duarte{7}, G. Katz-Greenberg{8}, E. King{9}, M. Levan{10}, A. Matas{11}, D. LaPointe-Rudow{12}, W. McKinney{2}, H. Xiao{1}, C. Wooley{1}, K. Siegert{3}, C. Nystedt{3}, A. Israni{2}, J. Synder{3}, A. Waterman{13}, {1}Saint Louis Univ, St. Louis, MO, {2}Hennepin Health, Minneapolis, MN, {3}SRTR, Minneapolis, MN, {4}Johns Hopkins, Baltimore, MD, {5}Mayo Clinic, Rochester, MN, {6}Univ. Michigan, Ann Arbor, MI, {7}Northwestern, Chicago, IL, {8}Duke, Durham, NC, {9}John Hopkins, Baltimore, MD, {10}NYU, New York, NY, {11}U Minnesota, Minneapolis, MN, {12}Mount Sinai, New York, NY, {13}Houston Methodist, Houston, TX

“Loss Aversion” and Framing Choices about the Use of XTx Pig Kidneys

  • M. K. Gusmano{1}, E. J. Gordon{2}, J. Gacki-Smith{3}, M. Matthews{4}, B. Lopez-Patino{4}, E. Randolph{1}, D. Manning{3}, K. Maschke{4}, {1}Lehigh University, Bethlehem, PA, {2}Surgery, Vanderbilt University Medical Center, Oak Park, IL, {3}Northwestern University, Chicago, IL, {4}The Hastings Center, Garrison, NY

Challenges to Monitoring Living Donor Candidates Long Term: Understanding Mobility of Living Donors in the Living Donor Collective

  • Y. Ahn{1}, A. Israni{2}, W. McKinney{2}, D. Schladt{1}, C. Nystedt{1}, C. Mejia{3}, A. Duarte{4}, A. Matas{5}, D. L. Rudow{6}, E. McMahon{7}, M. Doshi{8}, P. Dean{9}, G. Katz-Greenberg{10}, J. Snyder{11}, A. Waterman{12}, K. Lentine{13}, {1}SRTR, Minneapolis, MN, {2}Hennepin Healthcare, Univ of MN, Minneapolis, MN, {3}Johns Hopkins, Baltimore, MD, {4}Northwestern, Chicago, IL, {5}Univ of MN, Minneapolis, MN, {6}Mount Sinai Hospital, New York, NY, {7}Univ of Pittsburgh, Pittsburgh, PA, {8}Univ of Michigan, Ann Arbor, MI, {9}Mayo Clinic, Rochester, MN, {10}Duke Univ, Durham, NC, {11}HHRI, Minneapolis, MN, {12}Houston Methodist Hospital, Houston, TX, {13}Saint Louis Univ, St. Louis, MO

Follow Transplant on